Elekta Unveils New Neuroscience Solution for Leksell Gamma Knife at AANS

April 16, 2012 — Elekta is revealing innovations for Leksell Gamma Knife Perfexion this week at the 2012 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Miami.

"Once again, AANS will give us the opportunity to demonstrate to neurological surgeons that Gamma Knife radiosurgery is a continually evolving technique," says Jay Hoey, executive vice president, Elekta North America. "The latest example is the capability to exchange information, such as treatment plans, treatment record and protocols, both pre- and post-treatment, putting electronic medical records at your fingertips and allowing you to see all of your treatment statistics in one convenient dashboard. The result is a better flow of patient care and improved use of time and resources."

In addition to the latest product enhancements, Elekta will highlight characteristics of Leksell Gamma Knife Perfexion, including its dedication to intracranial cases, complete solution integration, "shrink-wrap" dose conformity and proven clinical efficacy. Demonstrations of the system will emphasize that Perfexion is designed to minimize risk of human error and radiation toxicity, while optimizing accuracy and dose conformance.

At the meeting Elekta is also exhibiting several other solutions that improve the management of neurological and neurosurgical cases, including:

  • Extend System for frameless, multi-session hypofractionation Gamma Knife radiosurgery;
  • Elekta Neuromag Triux magnetoencephalography (MEG) system;
  • Leksell Stereotactic System for functional neurosurgery; and
  • Leksell SurgiPlan 10, Elekta's image-based neurosurgical planning software specifically designed for the Leksell Stereotactic System.

 

For more information: www.elekta.com


Related Content

News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | Radiation Oncology

September 6, 2023 — Nina D’Abreo, MD, has been named as chief of the Division of Hematology and Medical Oncology at NYU ...

Time September 06, 2023
arrow
News | Radiation Oncology

August 30, 2023 — Elekta and the IAEA have signed a partnership agreement to jointly pursue common interests, including ...

Time August 30, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 28, 2023 — TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA, announced that ...

Time August 28, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
Subscribe Now